JFNAX vs. FBTCX
Compare and contrast key facts about Janus Henderson Global Life Sciences Fund Class A (JFNAX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX).
JFNAX is managed by Janus Henderson. It was launched on Dec 31, 1998. FBTCX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
JFNAX vs. FBTCX - Performance Comparison
Loading graphics...
JFNAX vs. FBTCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JFNAX Janus Henderson Global Life Sciences Fund Class A | -3.77% | 24.61% | 3.41% | 7.35% | -2.86% | 6.59% | 25.42% | 28.98% | 4.00% | 22.35% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 2.09% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
Returns By Period
In the year-to-date period, JFNAX achieves a -3.77% return, which is significantly lower than FBTCX's 2.09% return. Over the past 10 years, JFNAX has outperformed FBTCX with an annualized return of 10.96%, while FBTCX has yielded a comparatively lower 10.32% annualized return.
JFNAX
- 1D
- 3.08%
- 1M
- -5.56%
- YTD
- -3.77%
- 6M
- 11.78%
- 1Y
- 21.47%
- 3Y*
- 10.49%
- 5Y*
- 7.15%
- 10Y*
- 10.96%
FBTCX
- 1D
- 5.09%
- 1M
- -0.81%
- YTD
- 2.09%
- 6M
- 15.10%
- 1Y
- 54.26%
- 3Y*
- 17.00%
- 5Y*
- 6.73%
- 10Y*
- 10.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
JFNAX vs. FBTCX - Expense Ratio Comparison
JFNAX has a 0.98% expense ratio, which is lower than FBTCX's 1.75% expense ratio.
Return for Risk
JFNAX vs. FBTCX — Risk / Return Rank
JFNAX
FBTCX
JFNAX vs. FBTCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class A (JFNAX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JFNAX | FBTCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.06 | 1.90 | -0.84 |
Sortino ratioReturn per unit of downside risk | 1.52 | 2.49 | -0.97 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.32 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 1.78 | 3.08 | -1.31 |
Martin ratioReturn relative to average drawdown | 4.89 | 12.19 | -7.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JFNAX | FBTCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.06 | 1.90 | -0.84 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.46 | 0.29 | +0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.63 | 0.42 | +0.21 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.83 | 0.27 | +0.56 |
Correlation
The correlation between JFNAX and FBTCX is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
JFNAX vs. FBTCX - Dividend Comparison
JFNAX's dividend yield for the trailing twelve months is around 4.73%, more than FBTCX's 1.65% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JFNAX Janus Henderson Global Life Sciences Fund Class A | 4.73% | 4.56% | 5.74% | 4.28% | 0.08% | 9.90% | 7.82% | 6.18% | 13.55% | 1.03% | 0.97% | 8.93% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.65% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
Drawdowns
JFNAX vs. FBTCX - Drawdown Comparison
The maximum JFNAX drawdown since its inception was -31.07%, smaller than the maximum FBTCX drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for JFNAX and FBTCX.
Loading graphics...
Drawdown Indicators
| JFNAX | FBTCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -31.07% | -64.04% | +32.97% |
Max Drawdown (1Y)Largest decline over 1 year | -9.71% | -13.63% | +3.92% |
Max Drawdown (5Y)Largest decline over 5 years | -22.29% | -37.26% | +14.97% |
Max Drawdown (10Y)Largest decline over 10 years | -27.39% | -39.37% | +11.98% |
Current DrawdownCurrent decline from peak | -6.65% | -2.75% | -3.90% |
Average DrawdownAverage peak-to-trough decline | -6.31% | -23.21% | +16.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.63% | 3.75% | -0.12% |
Volatility
JFNAX vs. FBTCX - Volatility Comparison
The current volatility for Janus Henderson Global Life Sciences Fund Class A (JFNAX) is 6.00%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 9.37%. This indicates that JFNAX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JFNAX | FBTCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.00% | 9.37% | -3.37% |
Volatility (6M)Calculated over the trailing 6-month period | 10.64% | 17.02% | -6.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.86% | 25.99% | -8.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.70% | 23.48% | -7.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.41% | 24.66% | -7.25% |